IP Library Granted Patent US 9,458,069
Granted Patent B2
US 9,458,069 · App. 13/913,795 · Granted Oct 4, 2016

Methods and compositions for the recombinant biosynthesis of n-alkanes

Inventors: Nikos Basil Reppas (Brookline, MA); Christian Perry Ridley (Acton, MA)
Assignee: JOULE UNLIMITED TECHNOLOGIES, INC.
C07C9/00C07C11/02C07C47/02C12N9/0004C12P5/02C12P5/026C12P7/04C10G2300/4043Y02P20/52Y02P30/446
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,458,069
App. No.
13/913,795
Granted
Oct 4, 2016
Kind
B2
Abstract

The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into n-alkanes, and in particular the use of such organisms for the commercial production of n-alkanes and related molecules.

Claims (20)

1. An engineered cyanobacterium comprising a recombinant acyl-ACP reductase (AAR) enzyme and a recombinant alkanal decarboxylative monooxygenase (ADM) enzyme, wherein the AAR enzyme converts acyl-ACP to alkanal, and wherein the ADM enzyme converts alkanal to at least one n-alkane.

2. The engineered cyanobacterium of claim 1 , wherein exposure of the engineered cyanobacterium to light and inorganic carbon results in the conversion of said carbon by said engineered cynanobacterium into n-alkanes, wherein at least one of said n-alkanes is selected from the group consisting of n-tridecane, n-tetradecane, n-pentadecane, n-hexadecane, and n-heptadecane, and wherein the amount of said n-alkanes produced is between 0.1% and 5% dry cell weight and at least two times the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking said recombinant AAR and ADM enzymes.

3. The engineered cyanobacterium of claim 1 , wherein at least one of the recombinant enzymes is heterologous with respect to the engineered cyanobacterium.

4. The engineered cyanobacterium of claim 1 , wherein the engineered cyanobacterium further produces at least one n-alkene or n-alkanol.

5. The engineered cyanobacterium of claim 4 , wherein the engineered cyanobacterium produces at least one n-alkene or n-alkanol selected from the group consisting of n-pentadecene, n-heptadecene, and 1-octadecanol.

6. The engineered cyanobacterium of claim 1 , wherein the at least one n-alkane comprises predominantly n-heptadecane, n-pentadecane, or a combination thereof.

7. The engineered cyanobacterium of claim 1 , wherein the enzymes are encoded by genes which are part of an operon.

8. The engineered cyanobacterium of claim 1 , wherein the enzymes are encoded by a plasmid.

9. The engineered cyanobacterium of claim 1 , wherein the enzymes are encoded by recombinant genes incorporated into the genome of the engineered cyanobacterium.

10. The engineered cyanobacterium of claim 1 , wherein the enzymes are encoded by genes which are present in multiple copies in the engineered cyanobacterium.

11. The engineered cyanobacterium of claim 1 , wherein the enzymes are encoded by genes which are part of an operon, and wherein the expression of the genes is controlled by a single promoter.

12. The engineered cyanobacterium of claim 1 , wherein exposure of the engineered cyanobacterium to light and inorganic carbon results in the conversion of the carbon by the engineered cynanobacterium into n-alkanes.

13. The engineered cyanobacterium of claim 1 , wherein at least one of the n-alkanes is selected from the group consisting of n-tridecane, n-tetradecane, n-pentadecane, n-hexadecane, and n-heptadecane.

14. The engineered cyanobacterium of claim 1 , wherein the amount of the n-alkanes produced by the engineered cyanobacterium upon culture is between 0.1% and 5% dry cell weight and at least two times the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking the recombinant AAR and ADM enzymes.

15. The engineered cyanobacterium of claim 1 , wherein the amount of the n-alkanes produced by the engineered cyanobacterium upon culture is greater than the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking the recombinant AAR and ADM enzymes.

16. The engineered cyanobacterium of claim 1 , wherein each of the recombinant enzymes is heterologous with respect to the engineered cyanobacterium.

17. The engineered cyanobacterium of claim 1 , wherein the engineered cyanobacterium further produces at least one n-alkene.

18. The engineered cyanobacterium of claim 1 , wherein the engineered cyanobacterium further produces at least one n-alkanol.

19. The engineered cyanobacterium of claim 1 , wherein the at least one n-alkane comprises predominantly n-heptadecane.

20. The engineered cyanobacterium of claim 1 , wherein the at least one n-alkane comprises predominantly n-pentadecane.

Assignments (4)
SECURITY INTEREST Recorded Jun 23, 2016
From: JOULE UNLIMITED TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 039140/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 3, 2016
From: REPPAS, NIKOS BASIL; RIDLEY, CHRISTIAN PERRY
To: JOULE BIOTECHNOLOGIES, INC.
Reel/Frame 037887/0515 →
CHANGE OF NAME Recorded Mar 3, 2016
From: JOULE BIOTECHNOLOGIES, INC.
To: JOULE UNLIMITED, INC.
Reel/Frame 037994/0582 →
CHANGE OF NAME Recorded Mar 3, 2016
From: JOULE UNLIMITED, INC.
To: JOULE UNLIMITED TECHNOLOGIES, INC.
Reel/Frame 037994/0588 →
Continuity (7)
Continuation 13335886 · Dec 22, 2011
Continuation 13051807 · Mar 18, 2011
Continuation 12879862 · Sep 10, 2010
Continuation 12759657 · Apr 13, 2010
Provisional Application 61224463 · Jul 9, 2009
Provisional Application 61228937 · Jul 27, 2009
Related Publication 20140005439A1 · Jan 2, 2014